No AKI | Transient AKI | Persistent AKI | p | |
---|---|---|---|---|
Mean arterial pressure (mmHg) | ||||
Day 1 | 86 ± 16 | 87 ± 13 | 84 ± 15 | 0.55 |
Day 2 | 89 ± 16 | 88 ± 11 | 86 ± 18 | 0.85 |
Day 3 | 86 ± 12 | 90 ± 17 | 84 ± 12 | 0.72 |
Pulse pressure (mmHg) | ||||
Day 1 | 35 ± 6 | 35 ± 6 | 34 ± 6 | 0.78 |
Day 2 | 36 ± 7 | 34 ± 5 | 35 ± 7 | 0.84 |
Day 3 | 34 ± 5 | 37 ± 8 | 35 ± 5 | 0.69 |
Norepinephrine use (%) | ||||
Day 1 | 19 | 32 | 38 | 0.33 |
Day 2 | 18 | 30 | 44 | 0.27 |
Day 3 | 8 | 10 | 27 | 0.26 |
Heart rate (bpm) | ||||
Day 1 | 83 ± 18 | 93 ± 20 | 92 ± 22 | 0.18 |
Day 2 | 81 ± 16 | 86 ± 15 | 91 ± 19 | 0.16 |
Day 3 | 80 ± 13 | 85 ± 14 | 95 ± 20 | 0.05 |
Lactate (mmo/L) | ||||
Day 1 | 1.88 (1.66; 2.55) | 1.88 (1.44; 2.77) | 2.33 (1.77; 3.11) | 0.18 |
Day 2 | 1.83 (1.44; 2.19) | 1.72 (1.36; 2.11) | 2.33 (1.36; 2.11) | 0.16 |
Day 3 | 1.77 (1.5; 2.0) | 1.55 (1.11; 2.33) | 2.0 (1.66; 2.33) | 0.48 |
Serum chloride (mEq/L) | ||||
Day 1 | 107 ± 7.8 | 105 ± 5 | 106 ± 6 | 0.71 |
Day 2 | 106 ± 7 | 108 ± 5 | 107 ± 8 | 0.79 |
Day 3 | 106 ± 6 | 106 ± 6 | 108 ± 9 | 0.69 |
Fluid balance—24 h (mL) | ||||
Day 1 | 273 (− 429; 675) | 454 (− 520; 849) | 311 (70; 981) | 0.58 |
Day 2 | 89 (− 272; 358) | 217 (− 168; 1950) | 839 (98; 1600) | 0.07 |
Day 3 | − 467 (− 621; 473)a,b | 961 (636; 1624) | 531 (34; 1275) | 0.01 |
Renal RI | ||||
Day 1 | 0.65 ± 0.077b | 0.64 ± 0.07b | 0.71 ± 0.08 | < 0.01 |
Day 2 | 0.63 ± 0.07b | 0.64 ± 0.06b | 0.71 ± 0.09 | < 0.01 |
Day 3 | 0.64 ± 0.05 | 0.64 ± 0.07 | 0.69 ± 0.08 | 0.12 |